-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics Director Anne Prener Reports Sale of Common Shares Worth $5,619.46

PUBT·11/16/2026 21:17:14
Listen to the news
Keros Therapeutics Director Anne Prener Reports Sale of Common Shares Worth $5,619.46
  • Keros Therapeutics director Anne Prener sold 574 shares of common stock at $9.79 each on Nov. 12, 2026.
  • Following the sale, Prener directly owned 13,212 shares, according to the Form 4 dated Nov. 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001797917-26-000009), on November 16, 2026, and is solely responsible for the information contained therein.